Notch Signaling and Alloreactivity.

Area of Science:

• Immunology
• Transplantation Biology
• Molecular Medicine

Background:

• Solid organ and hematopoietic cell transplantation are life-saving procedures.
• Organ rejection and graft-versus-host disease remain significant challenges.
• Notch signaling plays a critical role in regulating immune responses relevant to transplantation.

Purpose of the Study:

• To investigate the role of Notch signaling in transplantation immunity.
• To evaluate Notch inhibition as a strategy to prevent transplant rejection and graft-versus-host disease.
• To explore the safety and efficacy of targeting Notch ligands versus systemic Notch blockade.

Main Methods:

• Preclinical models of T cell alloimmunity and transplantation.
• Assessment of Notch signaling pathways in T cells.
• Evaluation of Notch inhibition strategies, including systemic blockade and ligand targeting.
• Analysis of immune responses, including T cell polarization and alloantibody deposition.

Main Results:

• Notch inhibition in T cells prevented graft-versus-host disease and organ rejection.
• Notch blockade promoted the development of regulatory T cells and suppressed proinflammatory responses.
• Targeting Delta-like Notch ligands, but not systemic blockade with γ-secretase inhibitors, avoided observed toxicities.
• Notch ligand blockade also reduced alloantibody deposition and chronic rejection.

Conclusions:

• Notch signaling is a central regulator of alloreactivity in transplantation.
• Targeting Notch ligands offers a safe and effective strategy to induce immune tolerance after transplantation.
• Further translation of these preclinical findings into clinical transplantation medicine is warranted.